Epstein Secrets

50M over a five year horizon. Best, David David W. Carter President—DaCart Capital LLC <DaCart Pre

in NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

year horizon. Best, David EFTA00368798 David W. Carter President—DaCart Capital LLC <DaCart Pre

n NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (5096/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

50M over a five year horizon. Best, David David W. Carter President—DaCart Capital LLC <DaCart Pre

gards, James Dear James, EFTA00368781 Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

50M over a five year horizon. Best, David David W. Carter President—DaCart Capital LLC <DaCart Pre

n NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (5096/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

50M over a five year horizon. Best, David David W. Carter President—DaCart Capital LLC <DaCart Pre

in NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

50M over a five year horizon. Best, David David W. Carter EFTA00369254 President—DaCart Capital L

in NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

year horizon. EFTA00359717 Best, David David W. Caner President—DaCart Capital LLC EFTA00359718

t me know. Thank you. James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their

r your consideration. Kind regards, David David W. Carter President—DaCart Capital LW 1485 Main St

cal need to reduce the 45% failure rate of coronary artery by-pass grafts. This is a major unmet medical need in both Russia and the United States. Russian Venture Capital has agreed to provide approximately half of the capital ($3.0M) to launch MALI in its Series A Round. I need to find the matching approximate $3.5M.

r your consideration. Kind regards, David David W. Carter President—DaCart Capital LLC 1485 Main S

cal need to reduce the 45% failure rate of coronary artery by-pass grafts. This is a major unmet medical need in both Russia and the United States. Russian Venture Capital has agreed to provide approximately half of the capital ($3.0M) to launch MAJI in its Series A Round. I need to find the matching approximate $3.5M.

r your consideration. Kind regards, David David W. Carter EFTA00351819 President—DaCart Capital L

cal need to reduce the 45% failure rate of coronary artery by-pass grafts. This is a major unmet medical need in both Russia and the United States. Russian Venture Capital has agreed to provide approximately half of the capital ($3.0M) to launch MAJI in its Series A Round. I need to find the matching approximate $3.5M.